Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Onyx Pharmaceuticals Inc. (ONXX), the biotechnology company said to have rebuffed an initial takeover bid from Amgen Inc. (AMGN), is involved with several potential purchasers, Chief Executive Officer N. Anthony Coles said. “The process is ongoing with multiple parties currently engaged in discussions,” Coles said yesterday during a conference call after the company released second-quarter earnings. He said the South San Francisco, California-based company wouldn’t comment further.
Help employers find you! Check out all the jobs and post your resume.
